Ambassador Nazri: US State Dept displeased with PM Anwar's comments on Gaza conflict, wanted Putrajaya to sympathise with Israel
Around 20 million people need to be vaccinated with Moderna’s updated Covid-19 vaccine for the company to reach US$2 billion in 2023 sales from the private market, a figure four analysts told Reuters was achievable. Moderna forecast US$6 billion to US$8 billion for sales of its Covid-19 vaccine in 2023, US$2 billion to US$4 billion of which is expected to come from the commercial market. Previously signed government contracts would account for the rest.That forecast was called into question last month, when Pfizer lowered its full-year outlook for sales of its Covid-19 shot by about US$2 billion due to lower-than-expected vaccination rates.
The company’s RSV vaccine, which it aims to launch in the United States in 2024, was found to be 82.4 per cent effective in older adults with three or more symptoms in a late-stage trial. It would compete with recently approved vaccines from Pfizer and GSK.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: malaymail - 🏆 1. / 86 Read more »
Source: fmtoday - 🏆 5. / 72 Read more »
Source: staronline - 🏆 4. / 75 Read more »
Source: staronline - 🏆 4. / 75 Read more »
Source: fmtoday - 🏆 5. / 72 Read more »
Source: fmtoday - 🏆 5. / 72 Read more »